Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous properties

PLoS One. 2014 Jun 6;9(6):e99037. doi: 10.1371/journal.pone.0099037. eCollection 2014.

Abstract

L-asparaginase having low glutaminase has been a key therapeutic agent in the treatment of acute lymphpoblastic leukemia (A.L.L). In the present study, an extracellular L-asparaginase with low glutaminase activity, produced by Bacillus licheniformis was purified to homogeneity. Protein was found to be a homotetramer of 134.8 KDa with monomeric size of 33.7 KDa and very specific for its natural substrate i.e. L-asparagine. The activity of purified L-asparaginase enhanced in presence of cations including Na+ and K+, whereas it was moderately inhibited in the presence of divalent cations and thiol group blocking reagents. The purified enzyme was maximally active over the range of pH 6.0 to 10.0 and temperature of 40°C and enzyme was stable maximum at pH 9.0 and -20°C. CD spectra of L-asparaginase predicted the enzyme to consist of 63.05% α-helix and 3.29% β-sheets in its native form with T222 of 58°C. Fluorescent spectroscopy showed the protein to be stable even in the presence of more than 3 M GdHCl. Kinetic parameters Km, Vmax and kcat of purified enzyme were found as 1.4×10(-5) M, 4.03 IU and 2.68×10(3) s(-1), respectively. The purified L-asparaginase had cytotoxic activity against various cancerous cell lines viz. Jurkat clone E6-1, MCF-7 and K-562 with IC50 of 0.22 IU, 0.78 IU and 0.153 IU respectively. However the enzyme had no toxic effect on human erythrocytes and CHO cell lines hence should be considered potential candidate for further pharmaceutical use as an anticancer drug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification*
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Asparaginase / chemistry
  • Asparaginase / isolation & purification*
  • Asparaginase / metabolism
  • Asparaginase / pharmacology*
  • Bacillus / chemistry
  • Bacillus / enzymology*
  • CHO Cells
  • Cell Line, Tumor
  • Cricetulus
  • Enzyme Stability
  • Glutaminase / chemistry
  • Glutaminase / isolation & purification
  • Glutaminase / metabolism
  • Glutaminase / pharmacology
  • Humans
  • Neoplasms / drug therapy
  • Substrate Specificity

Substances

  • Antineoplastic Agents
  • Asparaginase
  • Glutaminase

Grants and funding

The author Richi V. Mahajan thanks Council of Scientific and Industrial Research (CSIR), New Delhi, for fellowship support. The funders had no role in study design, data collection and analysis, expenses of experimentation equipment and chemicals, decision to publish, or preparation of the manuscript.